4
Changes in Ownership
Dolby Laboratories, Inc. Filed Acc 0001209191-23-030821
President and CEO sold 9,030 shares at $83.65 ($755,351)
- President and CEO acquired 9,030 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| YEAMAN KEVIN J President and CEO | 2023-05-16 | Option exercise | +9,030 | $42.98 | $388,109 | 60,909 | I: show line 1 in the form |
| YEAMAN KEVIN J President and CEO | 2023-05-16 | Sale | −9,030 | $83.65 | $755,351 | 51,879 | I: show line 2 in the form |
| Open-market sales · 9,030 sh · avg $83.65 · $755,351 | |||||||
Table II: Derivative
| Insider | Date | Transaction | Shares | Price | Value | Exercise | Expires | Underlying | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|
| YEAMAN KEVIN J President and CEO | 2023-05-16 | Option exercise · Employee Stock Option (Right to Buy) | −9,030 | 162,786 | I: show line 3 in the form |
Loading xslF345X04/doc4.xml…